The results showed that, after treatment with ATO in breast cancer cells, the mRNA and protein levels of RhoB and PTEN were significantly upregulated, while the protein levels of p-AKT were significantly downregulated (Figures 3(a) and 3(c)). The gene discussed is AKT1; the disease is breast carcinoma.